11:09 AM EDT, 10/13/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts opened the week higher late Monday morning, rising 0.94% to 1,560.11 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and biotech firm Evaxion ( EVAX ) , which climbed 9.2% and 3.4%, respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) and 3D printer company Materialise (MTLS), which advanced 2.7% and 2.4%, respectively.

The decliners from continental Europe were led by biopharmaceutical company Genfit ( GNFT ) and telecommunications company Nokia ( NOK ) , which fell 1.5% each. They were followed by internet advertising firm Criteo ( CRTO ) and medical device maker EDAP TMS ( EDAP ) , which lost 1.4% and 1%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana ( NCNA ) and Adaptimmune Therapeutics ( ADAP ) , which surged 15% and 10%, respectively. They were followed by pharmaceutical company Silence Therapeutics ( SLN ) and biopharmaceutical company Amarin ( AMRN ) , which rose 5.4% and 5.2%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and biotech company Trinity (TRIB), which dropped 15% and 4.8%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and tobacco company British American Tobacco ( BTI ) , which were down 2.8% and 1.3%, respectively.